Corp Bruker serves as Executive at Bruker Cellular Analysis, Inc., where they oversee executive responsibilities. Since joining the company, Corp Bruker has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 2, 2023 involved transacting 1,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Oct 2, 2023 | CELL | $0 | Other | 1,000 | $N/A | Discretionary |
Corp Bruker currently holds 1,000 shares of Bruker Cellular Analysis, Inc. (CELL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Corp Bruker has been a net neutral trader of CELL stock. They have purchased $0 and sold $0 worth of shares.
Corp Bruker's most recent insider trade was on Oct 2, 2023, when they sold 1,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted